These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12792361)

  • 1. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco.
    McFarland W; Chen S; Hsu L; Schwarcz S; Katz M
    J Acquir Immune Defic Syndr; 2003 May; 33(1):96-103. PubMed ID: 12792361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999.
    Hsu LC; Vittinghoff E; Katz MH; Schwarcz SK
    J Acquir Immune Defic Syndr; 2001 Dec; 28(4):345-50. PubMed ID: 11707671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of socioeconomic status on survival with AIDS.
    Katz MH; Hsu L; Lingo M; Woelffer G; Schwarcz SK
    Am J Epidemiol; 1998 Aug; 148(3):282-91. PubMed ID: 9690366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy. Lazio AIDS Surveillance Collaborative Group.
    Rapiti E; Porta D; Forastiere F; Fusco D; Perucci CA
    Epidemiology; 2000 Sep; 11(5):496-501. PubMed ID: 10955400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
    Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987-1996.
    Schwarcz SK; Hsu LC; Vittinghoff E; Katz MH
    Am J Epidemiol; 2000 Jul; 152(2):178-85. PubMed ID: 10909955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDS.
    Friedman SR; West BS; Pouget ER; Hall HI; Cantrell J; Tempalski B; Chatterjee S; Hu X; Cooper HL; Galea S; Des Jarlais DC
    PLoS One; 2013; 8(2):e57201. PubMed ID: 23437341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
    Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
    Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS.
    Scheer S; Chu PL; Klausner JD; Katz MH; Schwarcz SK
    Lancet; 2001 Feb; 357(9254):432-5. PubMed ID: 11273063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons--San Francisco, 1981-2012.
    Djawe K; Buchacz K; Hsu L; Chen MJ; Selik RM; Rose C; Williams T; Brooks JT; Schwarcz S
    J Infect Dis; 2015 Nov; 212(9):1366-75. PubMed ID: 26044289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?
    Borrell C; Rodríguez-Sanz M; Pasarín MI; Brugal MT; García-de-Olalla P; Marí-Dell'Olmo M; Caylà J
    Eur J Public Health; 2006 Dec; 16(6):601-8. PubMed ID: 16698886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated risk of death for African Americans with AIDS, San Francisco, 1996-2002.
    Jain S; Schwarcz S; Katz M; Gulati R; McFarland W
    J Health Care Poor Underserved; 2006 Aug; 17(3):493-503. PubMed ID: 16960317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel use of AIDS surveillance data to assess the impact of initial treatment regimen on survival.
    Chen SY; Moss WJ; Pipkin SS; McFarland W
    Int J STD AIDS; 2009 May; 20(5):330-5. PubMed ID: 19386970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.
    Jacobson LP; Li R; Phair J; Margolick JB; Rinaldo CR; Detels R; Muñoz A
    Am J Epidemiol; 2002 Apr; 155(8):760-70. PubMed ID: 11943695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of survival following HIV-1 seroconversion after the introduction of HAART.
    Porter K; Babiker A; Bhaskaran K; Darbyshire J; Pezzotti P; Porter K; Walker AS;
    Lancet; 2003 Oct; 362(9392):1267-74. PubMed ID: 14575971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of progression to AIDS after HIV infection diagnosis in the pre- and post-HAART eras in a Brazilian AIDS-free cohort.
    Tancredi MV; Waldman EA
    Trans R Soc Trop Med Hyg; 2014 Jul; 108(7):408-14. PubMed ID: 24836061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.
    Hoffmann C; Wolf E; Fätkenheuer G; Buhk T; Stoehr A; Plettenberg A; Stellbrink HJ; Jaeger H; Siebert U; Horst HA
    AIDS; 2003 Jul; 17(10):1521-9. PubMed ID: 12824790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race, place and AIDS: the role of socioeconomic context on racial disparities in treatment and survival in San Francisco.
    Arnold M; Hsu L; Pipkin S; McFarland W; Rutherford GW
    Soc Sci Med; 2009 Jul; 69(1):121-8. PubMed ID: 19443092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.